Co-Authors
This is a "connection" page, showing publications co-authored by George Gao and Zhongjie Li.
Connection Strength
3.118
-
Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China. Lancet Reg Health West Pac. 2021 Mar; 8:100094.
Score: 0.928
-
Infectious disease trends in China since the SARS outbreak. Lancet Infect Dis. 2017 11; 17(11):1113-1115.
Score: 0.740
-
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 to Close Contacts, China, January-February 2020. Emerg Infect Dis. 2021 09; 27(9):2288-2293.
Score: 0.241
-
Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat Commun. 2021 05 31; 12(1):3249.
Score: 0.237
-
Comprehensive large-scale nucleic acid-testing strategies support China's sustained containment of COVID-19. Nat Med. 2021 05; 27(5):740-742.
Score: 0.236
-
One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China. Clin Infect Dis. 2021 01 27; 72(2):332-339.
Score: 0.232
-
Evidence for pre-symptomatic transmission of coronavirus disease 2019 (COVID-19) in China. Influenza Other Respir Viruses. 2021 01; 15(1):19-26.
Score: 0.224
-
Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet. 2020 07 04; 396(10243):63-70.
Score: 0.221
-
Risk Factors for Death Among the First 80 543 COVID-19 Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region. Clin Infect Dis. 2021 May 27.
Score: 0.059